India's health ministry denies supply disruptions, but activists allege a shortage of essential drugs.
Read moreBy Sharanya Hrishikesh
BBC News, Delhi
BBC News Health
'I'm a different person after having monkeypox'
"If you haven't lived through it, you have no idea the kind of pain this is," one man tells the BBC.
Top Stories
'I'm a different person after having monkeypox'
"If you haven't lived through it, you have no idea the kind of pain this is," one man tells the BBC.
Polio: Do we have to worry about it once again?
With nearly a million children being vaccinated in London, how worried should we be?
US doctor warns of many undiagnosed polio cases
The New York State medic says there could be hundreds, or even thousands, of infected people there.
North Korea claims to have recovered from Covid
There is widespread scepticism over North Korea's claim to have the world's lowest Covid death rate.
US declares monkeypox a public health emergency
The decision is expected to speed up the distribution of vaccines, treatments and federal resources.
New Zealand fully reopens borders after Covid
The country shut its borders in March 2020, a move that majorly impacted the tourism industry.
First monkeypox deaths reported outside Africa
Brazil and Spain report fatalities from the virus, but most infections are mild and overall risk is low.
Featured Contents
'I'm a different person after having monkeypox'
"If you haven't lived through it, you have no idea the kind of pain this is," one man tells the BBC.
Polio: Do we have to worry about it once again?
With nearly a million children being vaccinated in London, how worried should we be?
US doctor warns of many undiagnosed polio cases
The New York State medic says there could be hundreds, or even thousands, of infected people there.
North Korea claims to have recovered from Covid
There is widespread scepticism over North Korea's claim to have the world's lowest Covid death rate.
US declares monkeypox a public health emergency
The decision is expected to speed up the distribution of vaccines, treatments and federal resources.
New Zealand fully reopens borders after Covid
The country shut its borders in March 2020, a move that majorly impacted the tourism industry.
First monkeypox deaths reported outside Africa
Brazil and Spain report fatalities from the virus, but most infections are mild and overall risk is low.
Polio: Do we have to worry about it once again?
With nearly a million children being vaccinated in London, how worried should we be?
US doctor warns of many undiagnosed polio cases
The New York State medic says there could be hundreds, or even thousands, of infected people there.
North Korea claims to have recovered from Covid
There is widespread scepticism over North Korea's claim to have the world's lowest Covid death rate.
Features
Watch/Listen
Latest Updates
By Ian Youngs
Entertainment reporter in Edinburgh
By Malu Cursino
BBC News
By The Visual and Data Journalism Teams
BBC News
By Smitha Mundasad
Health reporter
Video content
Video caption: ‘I was a dentist before Ukraine War, I want to help others’ A Ukranian refugee family who are dentists are highlighting barriers preventing them from practising.
By Peter Hoskins
Business reporter
By Sarah Lee
BBC News
By Jessica Parker and Sira Thierij
BBC News, Malta
By Marie-Louise Connolly
BBC News NI Health Correspondent
Zero demand forces vaccine maker to halt Covid line
Vumani Mkhize
BBC Africa Business
Copyright: ReutersImage caption: Aspen Pharmacare says it will focus on anaesthetics instead A South African firm says it will stop making coronavirus vaccines at the end of the month because it hasn't received a single order.
Aspen Pharmacare's announcement was followed by reassurance from the Africa Centres for Disease Control that it was "doing everything to ensure that those buying vaccines are buying them from Africa".
In March, Aspen signed a deal with Johnson & Johnson to produce 450 million doses per year of its own branded version of a Covid-19 vaccine called Aspenovax.
At the time Aspen’s deal with Johnson & Johnson was called "a game-changer" in providing equitable vaccines to the continent.
The African Union has a target for 60% of all vaccines administered on the continent to be produced locally by 2040. But with only a fifth of Africans vaccinated, that demand has not materialised.
Aspen says it will now be forced to re-purpose some of its production lines to make anaesthetics.
